Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Chemours Company shares valued at $154,771 were sold by Scarborough Alvenia on Nov 07 ’24. At $20.64 per share, Scarborough Alvenia sold 7,500 shares. The insider’s holdings dropped to 16,645 shares worth approximately $0.29 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Scarborough Alvenia purchased 7,500 shares, netting a total of over 150,000 in proceeds.
Before that, Picho Diane I. had sold 2,684 shares from its account. In a trade valued at $50,519, the Interim Pres. – Titanium Tech traded Chemours Company shares for $18.82 each. Upon closing the transaction, the insider’s holdings decreased to 2,684 shares, worth approximately $0.35 million.
As published in a research note from UBS on July 09, 2024, Chemours Company [CC] has been rated up from a Neutral to a Buy and the price target has been revised to $30 from $28. Analysts at Mizuho started covering the stock with ‘”a Neutral”‘ outlook in a report released in early June. As of April 09, 2024, BMO Capital Markets has increased its “an Underperform” rating to a “an Outperform” for CC. Earlier on March 05, 2024, UBS downgraded its rating. Their new recommendation was “a Neutral” for CC stock which previously was a “a Buy”.
Analyzing CC Stock Performance
During the last five days, there has been a drop of approximately -3.68%. Over the course of the year, Chemours Company shares have dropped approximately -44.39%. Shares of the company reached a 52-week high of $32.70 on 01/02/24 and a 52-week low of $15.10 on 02/29/24. A 50-day SMA is recorded $19.59, while a 200-day SMA reached $22.45. Nevertheless, trading volume fell to 0.66 million shares from 1.12 million shares the previous day.
Support And Resistance Levels for Chemours Company (CC)
According to the 24-hour chart, there is a support level at 17.33, which, if violated, would cause prices to drop to 17.11. In the upper region, resistance lies at 17.72. The next price resistance is at 17.89. RSI (Relative Strength Index) is 32.02 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.50, which suggests the price will decrease in the coming days. Percent R is at 93.84%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
